| Released | Contributor | Author | Title | Pages | Price |
| 29-Nov-2009 | PriceTarget Research, Inc. |
N/A
| Emeritus Corporation has a current Overall Rating of C (Neutral). | 7 |
$25 |
| 26-Nov-2009 | New Constructs, LLC |
N/A
| ESC: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings | 19 |
$10 |
| 26-Nov-2009 | Pechala's Reports | Lubomir Pechala | EMERITUS CORPORATION (ESC=US) - REPORT FOR ACTIVE TRADERS | 4 |
$25 |
| 24-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Industry Report for HOSPITALS | 18 |
$49 |
| 23-Nov-2009 | PriceTarget Research, Inc. |
N/A
| Business & Misc Services Intelligence Monitor: overall outlook NEUTRAL - 25 new Leaders; 25 new Laggards. | 65 |
$20 |
| 23-Nov-2009 | Reuters Investment Profile |
N/A
| Emeritus Corp: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. | 12 |
$20 |
| 23-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Real Estate & Construction Industry Market Research and Competitive Analysis 2009 | 599 |
$299 |
| 23-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Plunkett's Health Care Technologies Overview 2010 (Summary) | 80 |
$199 |
| 23-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Real Estate & Construction Industry Trends, Statistics & Analysis 2009 (Summary) | 64 |
$199 |
| 23-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Health Care Industry Market Research and Competitive Analysis 2010 | 730 |
$299 |
0.29% Nasdaq 
0.11 (0.66%) 
Research Reports
